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Since its original application, gastrointestinal (GI) endoscopy has undergone many 
innovative transformations aimed at expanding the scope, safety, accuracy, 
acceptability and cost-effectiveness of this area of clinical practice. One method of 
achieving this has been to reduce the caliber of endoscopic devices. We propose the 
collective term ‘Miniature GI Endoscopy’. In this Opinion Review, the innovations in 
this field are explored and discussed. The progress and clinical use of the three main 
areas of miniature GI endoscopy (ultrathin endoscopy, wireless endoscopy and 
scanning fiber endoscopy) are described. The opportunities presented by these 
technologies are set out in a clinical context, as are their current limitations. Many of 
the positive aspects of miniature endoscopy are clear, in that smaller devices provide 
access to potentially all of the alimentary canal, while conferring high patient 
acceptability. This must be balanced with the costs of new technologies and 
recognition of device specific challenges. Perspectives on future application are also 
considered and the efforts being made to bring new innovations to a clinical platform 
are outlined. Current devices demonstrate that miniature GI endoscopy has a valuable 
place in investigation of symptoms, therapeutic intervention and screening. Newer 
technologies give promise that the potential for enhancing the investigation and 
management of GI complaints is significant. 
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Core tip: Miniature endoscopic devices play a growing role in the practice of 
gastroenterology and can come in many forms. They can offer easier access to the 
gastrointestinal tract, are often tolerated better than standard endoscopy and have the 
potential to boost diagnostic accuracy. Those properties give promise to 
advancements in therapeutic intervention and to screening for luminal disorders. 
Pitfalls remain, particularly with regard to cost, but the trend towards the application 
of miniature gastrointestinal endoscopy is clear and justifiable. 
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INTRODUCTION 
Gastrointestinal (GI) endoscopy has for many decades been an essential component 
in the practice of diagnosing and managing digestive diseases. Current endoscopic 
practice began with Schindler’s development of the flexible gastroscope in 1932[1]. 
Since that innovative step, approaches have been taken to expand the abilities of 
endoscopy, improve its safety and present exciting challenges to what further can be 
done. One aspect of this is the development of miniature endoscopes which have 
aimed to address various clinical problems. The progress of miniature endoscopic 
devices is largely dependent on that of optical technology and its resultant 
incorporation of that into clinical application.  
The use of an endoscopic device with a smaller caliber has many advantages in 
clinical practice. Tolerance and safety of invasive GI procedures can be improved, 
potentially leading to greater uptake and enhanced trust in a care provider. This 
feature of miniature endoscopy, combined with the potential for more portable 
devices, could have benefits for wider access to population screening for various GI 
diseases. Devices that demand less sedation and carry fewer complications add to 
arguments for the cost-effectiveness of miniature endoscopes. These features as well 
as the authors’ vision for future applications are outlined in this Opinion Review. 
The authors have both academic and clinical expertise in the development and use 
of miniature endoscopes to enhance patient care. They are aware of the present 
challenges to clinical practice, including rapid access to screening and diagnostics, 
improving early cancer detection rates and developing less invasive therapeutic 
interventions. Miniature endoscopy may have a place in addressing all of these 
challenges.  
The 3 main areas explored in the review are: ultrathin endoscopy; wireless capsule 
endoscopy; and scanning fiber endoscopy.  
 
ULTRATHIN ENDOSCOPY 
Ultrathin endoscopes have many uses in gastroenterology and they are lauded as safe, 
cost-effective and easy-to-use tools which carry benefits that standard endoscopes do 
not[2]. The first recorded use of unsedated ultrathin endoscopy (UTE) was in 1994 
when twenty healthy volunteers underwent esophagogastroduodenoscopy (EGD) 
using an Olympus GIF-N30 device[3]. Since then, its use has expanded into common 
practice in most endoscopy departments. In addition to diagnostic procedures, UTE 
has been used to varying degrees of success in therapeutic scenarios, such as self-
expanding metal stent insertion, long intestinal tube placement for small bowel 
obstruction and some endoscopic retrograde cholangiopancreatography (ERCP) 
cases[4–6]. 
The conventional design of ultrathin endoscopes is similar to that of standard 
endoscopes. However, shaft diameters tend to be around 6 mm or less, allowing 
insertion through the nasal cavity to perform transnasal endoscopy (TNE)[2]. Portable 
and disposable models of ultrathin endoscopes have the potential to change the 
approach taken to clinical practice. The newest devices have disposable sheaths which 
eliminate the need for instrument decontamination and allow multiple examinations 
to take place using the same device in quick succession. The light source, processor 
and screen are integrated into a portable digital processing unit[7] (Figure 1). The 
employment of a portable system can obviate transfer to a hospital unit, which in itself 
can cause inconvenience and distress to patients and carry significant cost to time and 
resources. The endoscopic test can instead take place in a setting that is more 
acceptable to such individuals[8]. One therapeutic procedure for which this may be 
pertinent is percutaneous endoscopic gastrostomy (PEG) insertion. Ultrathin 
transnasal endoscopes can be used to insert feeding tubes using the introducer 
method, which inserts the tube directly into the gastric lumen and eliminates the need 
for passage through the mouth[9]. This technique, combined with use of a portable 
endoscope serves to reduce the risk of cardiorespiratory side effects in selected at-risk 
cases[10]. 
Using tolerability assessment scores, unsedated transnasal endoscopy (TNE) is 
reported by patients as comparable to sedated conventional EGD (C-EGD)[11]. The 
tolerability, safety and effectiveness of UTE lends itself well to use in endoscopic 
screening for esophageal disorders such as Barrett’s esophagus (BE) and esophageal 
varices[11–13]. BE can be reliably diagnosed using UTE and the yield for intestinal 
metaplasia using smaller biopsy forceps is comparable to those used in C-EGD[14]. The 
productivity of a screening program is enhanced by portable, disposable models, 
opening up the possibility that screening using UTE can be a cost-effective measure. 
In a United States based Barrett’s screening study of 209 patients, unsedated TNE was 
significantly lower in cost compared to sedated C-EGD, with mobile endoscopy costs 
proving less costly than TNE delivered in a hospital setting[15]. This applied to both 
direct and indirect medical costs. Options for the setting of this test could also expand, 
with office-based esophagoscopy becoming a potential reality[13].  
UTE does carry drawbacks and limitations. Low-caliber endoscopes carry less 
capacity for constituent components (such as access channels for biopsy and 
therapeutic interventions); relatively lower image resolution and angle of view 
compared to C-EGD. There is some evidence that biopsies taken through an ultrathin 
channel carry comparable diagnostic yield for dysplasia to standard biopsies but 
larger studies are necessary[16]. The diagnostic accuracy of UTE for early superficial 
gastric cancers also continues to be prone to scrutiny in countries with high incidence 
such as Japan, albeit UTE being used for gastric cancer screening in this region[17].  
 
CAPSULE ENDOSCOPY 
The use of wireless capsule endoscopy (WCE) was first described in 2000 and has 
enjoyed widespread use since Food and Drug Administration approval in 2001[18]. The 
common application of WCE for identifying small bowel bleeding follows evidence 
that it is a superior diagnostic test to push enteroscopy and barium contrast studies[19]. 
It is a reliable test for Crohn’s disease, with a diagnostic yield as high as 71% and a 
high safety profile provided the risk of capsule retention is lowered by sufficient 
imaging or patency studies[20,21]. Improvements in diagnostic yield continue to be 
developed by widening field of view and increasing the number of recorded images, 
including the development of adaptive frame rates[22,23]. Various software tools have 
been developed to reduce reading time while maintaining the diagnostic yield. Their 
properties include omission of almost identical images, provisional selection of the 
most standout images and multiple-view modes[24]. The limitations of even very 
experienced and skilled readers in identifying pathologies are acknowledged. In 
response to this, the place of artificial intelligence in WCE is now recognized as a very 
real prospect. Applicable technology remains in the embryonic stages but over time, 
this, as well as patient and physician acceptance, are seen as barriers that can be 
overcome[25].  
Beyond diagnosing small bowel pathology, colon capsule endoscopes (CCE) have 
been produced in response to concerns over the resource intensiveness driven by 
increased demand for colonoscopies, the chance of failure of cecal intubation and 
suboptimal patient uptake due to the poor tolerance of more conventional 
endoscopy[26]. The second generation CCE-2 has two optical cameras at each end 
giving a 172 view and adaptive frame rate up to 35 frames per second. This provides 
bidirectional views in real time. Its dimensions are 31.5 mm by 11.6 mm and its 
recording capacity is ten hours. The software contains a polyp size estimation function 
and a flexible spectral imaging color enhancement for enhanced visualization[27]. 
Provided bowel preparation is excellent, detection of polyps > 6 mm and > 10 mm for 
the CCE-2 carries sensitivity and specificity rates of over 85%, supporting claims that 
this may be applicable in a screening setting[28]. In controlled settings, CCE have also 
been comparable to colonoscopy in assessing the colonic mucosa of those with 
inflammatory bowel disease[29,30]. 
Esophageal diseases such as BE and esophagitis may be detected using a capsule 
device. A blinded study comparing EGD as gold standard with the PillCam ESO 2 
device (Given Imaging Ltd., Yoqneam, Israel) yielded promising detection rates for 
BE and esophagitis with a sensitivity of 100% and a specificity of 74%, and a sensitivity 
of 80% and a specificity of 87%, respectively[31]. In an attempt to overcome the 
impairment to diagnostic sensitivity exacerbated by rapid esophageal transit, tethered 
wireless capsule endoscopes have been developed. For the detection of Barrett’s 
esophagus, early results have been mixed and further large scale studies in relevant 
populations are advocated[32]. WCE has also been trialed in the emergency setting of 
acute upper GI bleeding. A prospective study found it to be a feasible and safe way of 
detecting and stratifying such cases[33]. It may also have a place in future practice for 
screening and surveillance of esophageal varices. The current literature, with a pooled 
sensitivity of 72%, does not support its use over EGD[34].  
Active locomotion in capsules using mechanical actuation, in a crawling, inch-
worm or swimming motion has been proposed as a way of controlling transit through 
the GI tract and resisting peristalsis in cases where prolonged inspection of an 
abnormal lumen is desired. Development of such equipment has not reached clinical 
trial stage primarily due to power capacity issues and mechanical complexity[35]. 
Future development would depend on enhanced power storage or usage 
technology[36].  
Non-actuated wireless capsules have struggled to completely examine the stomach 
lumen, owing to its large size impeding full visualization[37]. However, a feasibility 
study has suggested that with one liter of simethicone-containing swallowed water, 
good views of the upper GI tract can be obtained[38]. More advanced software that 
incorporates larger frame rates and artificial intelligence may also potentiate the 
diagnostic accuracy of this approach. Magnetically guided wireless capsules have 
been developed to be able to better navigate the device around a fluid distended 
stomach. There may also be a role for this test in screening for gastric cancer, with 
provisional feasibility studies of asymptomatic patients showing promise[39]. 
Magnetically driven capsules also help to lower storage needs for power thus 
potentially allowing space for interventional tools[35]. Progress continues on the 
development of biopsy models, which have shown promise in in vitro and animal 
models[40]. Further application in clinical trials is needed before the potential for 
interventional WCE in healthcare can be realized. Robotic assistance in controlling 
magnetic wireless capsules has been the subject of some clinical trials, showing 
superiority of this method of actuation over manual manipulation of magnetically 
guided WCE on viewing installed targets on an ex-vivo colon model[41]. A multicenter 
blinded study of patients with upper abdominal complaints examined robotically-
assisted magnetically guided WCE with the gold standard of conventional 
gastroscopy and concluded that detection of focal lesions in the upper and lower 
stomach had comparable accuracy[42]. This device has also shown better diagnostic 
yield than EGD in patients presenting for investigation of iron deficiency anemia[43]. 
The evidence points towards WCE having a greater future role for diagnosis of GI 
disorders although it will require more time and research, particularly on the cost-
effectiveness front, to determine which manifestations warrant widespread 
application[43,44] (Figures 2-4). 
 
SCANNING SINGLE FIBER ENDOSCOPY 
Newer forms of optical technology have been developed to meet the demands for 
endoscopic imaging that is of higher resolution than UTE can provide[46] (Figure 5). 
Scanning single fiber endoscopy (SFE) involves narrow bands of light being projected 
onto tissue and reflecting back onto the fiber, before an image is created one pixel at a 
time. The resultant image is of a superior quality to those from an ultrathin endoscope 
of a similar caliber[47]. In gastrointestinal endoscopy, as well as permitting access to 
poorly accessible areas like the upper biliary tree and pancreas, SFE may have a place 
as an adjunct to more conventional endoscopes. One example of this could be more 
complete visualization of a lesion whenever full views are not obtained on a single 
plane. 
Spectrally-encoded scanning fiber endoscopy uses polychromatic light emissions 
from the endoscopic probe, encoded by wavelength which is then reflected from the 
surface and decoded outside the body to produce a one-dimensional impression. 
Rotation of the instrument builds information for a two-dimensional image of the 
visualized surface[46]. The endoscope can be as thin as 80-250 micrometers in diameter, 
limited only by the size of the light-emitting fiber and any accessory instruments[48,49]. 
Spectral encoded endoscopy using a single fiber can perform three-dimensional 
topological analysis and real-time subsurface imaging[50]. This multispectral SFE may 
be used in combination with white light endoscopy to collect wide field fluorescence 
images which can permit early detection of dysplasia and cancer[51]. Although 
research has shown progress in animal models, development of this technology for 
analyzing human tissue is required.  
SFE has been undertaken in limited cases to perform cholangioscopy in patients 
with pancreaticobiliary strictures. It is a feasible technology to directly view such areas 
with better resolution than current cholangioscopic tools[52]. A tethered SFE ‘capsule’ 
for conducting esophagoscopy has been developed, in what could represent an 
evolution of the tethered wireless capsule endoscope[53]. The patient swallows the 
device and images are transmitted live up the single fiber into a processor, in contrast 
with the tethered WCE which stores images for viewing at a later time. With the SFE 
capsule, real time images mean that pathologies and potential problems are identified 
at an immediate stage. Research into the application of SFE in real clinical scenarios is 
required but this has the potential for gastrointestinal endoscopy to be safer, more 
cost-effective, better tolerated and more advanced than current technology allows[47]. 
The progress of this technology continues at a rapid pace, with prototype devices as 
thin as a human hair that carry better resolution, being developed[54].  
 
CONCLUSION 
Miniature GI endoscopy has many forms and is in many ways a relative term. 
Through the recognition that endoscopy is an invasive procedure to which patients 
are prone to experiencing significant discomfort, and that accessibility to areas of the 
gastrointestinal tract requires development of existing equipment, endoscopes with 
narrower calibers have been produced. The three main domains in miniature 
endoscopy currently are ultrathin devices, scanning fiber endoscopes and wireless 
capsules. Within these domains many products are being developed at a rapid pace.  
The role of gastrointestinal endoscopy can be generally categorized into two 
aspects- diagnostic and therapeutic. From a healthcare perspective, it is clear that a 
suitably accurate means of diagnosing GI diseases, which is better tolerated and 
eventually more cost-effective than standard endoscopy warrants major consideration 
for future practice. Screening for various luminal GI diseases, in particular, malignant 
and pre-malignant conditions is a topical issue. We believe that miniature devices 
such as ultrathin endoscopes and capsules can bring a high quality screening service 
that satisfies the needs outlined by Wilson et al[55]. As evidenced above, the diagnostic 
capabilities of miniature endoscopic devices such as SFE and magnetically guided 
WCEs enhance today’s practice. Through the enhanced access provided by miniature 
endoscopy, therapeutic interventions like hemostasis and delivery of medication may 
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 Figure 1 The ‘EG Scan II’ system. A: The portable case with four main parts; B: The 
image processor (top left), disposable probe (top right), air tube (bottom right) and 
hand-held controller (bottom left); C: The system connected and ready for use; D: 
Close view of the capsule probe tip. Reproduced with permission from Sami SS et al. 
Copyright John Wiley and Sons. 
  
 Figure 2 Maneuvers of the magnetically guided wireless capsule endoscopy in the 
stomach. Reproduced with permission from Ching HL et al[43]. Copyright Thieme 
Group. 
  
 Figure 3 MicroCam Navi equipment (magnetically-assisted capsule endoscopy). 
Reproduced with permission from Ching HL et al[38]. Copyright Thieme Group. 
  
 Figure 4 Capsule endoscopy. A: Longitudinal view of the gastric body and lesser 
curve. B: Gastric antrum. C: Pre-pyloric erosion. D: Angioectasia in the cardia. E: 
Nonsteroidal anti-inflammatory drug-related erosive gastropathy. F: Fundic gland 
polyps. Reproduced with permission from Hale MF et al. Copyright Thieme Group. 
  
 Figure 5 Scanning single fiber endoscopy. A: Scanning fiber endoscopy (SFE) 
endoscope probes showing 9 mm rigid tip length of 1.2 mm diameter prototype and 
18 mm capsule length of 6.4 mm diameter TCE. A front view of the distal end of the 
TCE is shown in (B) illustrating that the TCE is a standard SFE probe with collection 
fibers modified for capsule use. The gastroesophageal junction of a human subject is 
shown in single 500-line RGB image contrast (C) compared to postprocessed ESI 
contrast of the same SFE image frame (D). The lighter esophageal tissue is more clearly 
differentiated from the red-colored gastric mucosa in the ESI image. Reproduced with 
permission from Lee CM et al[46]. Copyright John Wiley and Sons, Inc. 
